Skip to content
atgesundheitinstitute.com logo
  • Research
  • Treatment
  • Contact

Welcome to the ATGesundheit Institute

The mission of the ATGesundheit Institute is to carry out observational studies on patients undergoing investigational Oncolytic Virus &  Cancer Immunotherapy  treatment in cooperation with medical professionals. ATGesundheit Institute also reviews patient medical histories to enhance their health and safety. Oncolytic virus therapy combined with other therapies is a promising approach with potential to extend survival time and to improve quality of life.

therapeutic potential

Oncolytic immunotherapy is a new approach to cancer treatment. For ATGesundheit Institute by Rapo Yerape BH Ltd., Dr. Gesundheit and his team review patient’s medical data and evaluate if they are eligible for Oncolytic Virus treatment.

Please read our recently published research: Effective Treatment of Glioblastoma Multiforme With Oncolytic Virotherapy: A Case-Series in the May 2020 issue of Frontier in Oncology.

Beni Gesuntheit

Dr. Beni Gesundheit, MD PhD

Scientific Advisor,
Rapo Yerape BH Ltd.

Dr. Sahinbas

Dr. Hüseyin Sahinbas, MD

Physician,

Praxis für Hyperthermie

RESEARCH ON OVT FOR SPECIFIC

Cancers

brain

Glioblastoma (GBM)

breast cancer icon

Breast Cancer

Other Solid Tumors

OV Research

Oncolytic Viruses - Genetically Engineering the Future of Cancer Therapy

The ability to genetically engineer oncolytic viruses (OV) in order to minimize side effects and improve the selective targeting of tumor cells is opening up novel opportunities for treating cancer. Understanding the mechanisms involved and the complex interaction between the viruses and the immune system will undoubtedly help guide the development of new strategies. 

EDITED BY: Benjamin Gesundheit and Joshua P. Rosenzweig
PUBLISHED IN: Frontiers in Oncology and Frontiers in Immunology 

READ MORE

FAQ

What is OV?

Oncolytic Virus (OV) Immunotherapy utilizes selected viruses to target tumor cell types without harming healthy tissue. Their selectivity is attributed to different biological features of the surface of cancer tumor cells that are absent in normal human cells. Once the infected tumor cell is destroyed by OVs, the amplified OVs can infect and target adjacent tumor cells, eventually eliminating the entire tumor mass.

How does OV work with immunotherapy

OV Therapy provides a direct tumor-killing (oncolytic) effect and a parallel activation of the patient’s immune system against tumor cells (immunotherapy). Since 2010 immunotherapy has been revolutionizing oncology treatment and has provided new biotechnology products for standard clinical practice. These products have included the first licensed OV Therapy indicated for the treatment of melanoma, which stands as proof of concept for the entire OV Therapy field. 

Are there any side effects from treatment?

Dr. Thaller’s patients have experienced relatively minimal side effects. Fever is a side effect that is also a sign of a successful immune response. When necessary fever can be prevented or reduced using standard analgesics. No long-term side effects have been reported. 

What is the estimated treatment schedule for OV therapy?
OV treatments are usually scheduled for between 2-6 weeks. The time interval depends on the status of the illness and the patient’s highly individual immune response. After 12-18 months of intense treatment, there is generally a quarterly follow up schedule in order to prevent a relapse.
How much does the therapy cost?

The cost depends mostly on the individual treatment interval. Estimated costs for the first year which involves intensive treatment is between 50-100 thousand Euro. Please note that OV therapy is investigational and may not be covered by health insurance.

The above estimate does not include diagnostic testing or travel expenses.

Diagnostics are usually covered for patients with German health insurance. It may also be covered by other insurance policies. One  would need to check regarding their individual policy.

Depending on where one lives travel expenses will differ. Please assess your  travel costs in order to come to the clinic in Germany for treatment.

Questions?

Please take the opportunity to contact us either with a general query or to begin the patient application process.

About us

The ATGesundheit Institute website presents information about oncolytic virus (OV) cancer immunotherapy for glioblastoma multiforme (GBM), solid tumors and breast cancer. Our website is dedicated to exploring the therapeutic potential of OVs for incurable tumors and the therapeutic mechanisms of various OVs.

Cancers

  • GBM
  • BREAST CANCER
  • SOLID TUMORS

Contact US

ATGESUNDHEIT Institute
CONTACT FORMS
Email
office@atgesundheitinstitute.com
Copyright © 2022 | ATGesundheit Institute
Contact | Terms of Use | Privacy Policy | Imprint |Accessibility
Scroll to Top
Cookies: To make this site work properly, we sometimes place small data files called cookies on your device. Most big websites do this too.
Accept
Privacy Policy
Change Settings
Cookie Box Settings Cookie Settings
Cookie Box Settings Cookie Settings

Privacy settings

Decide which cookies you want to allow. You can change these settings at any time. However, this can result in some functions no longer being available. For information on deleting the cookies, please consult your browser’s help function. Learn more about the cookies we use.

With the slider, you can enable or disable different types of cookies:

  • Block all
  • Essential
  • Functionality
  • Analytics

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages

This website won't:

  • Remember your login details
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Functionality: Remember social media settings
  • Functionality: Remember selected region and country

This website won't:

  • Remember your login details
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Tailor information and advertising to your interests based on e.g. the content you have visited before. (Currently we do not use targeting or targeting cookies.
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions

This website won't:

  • Remember your login details
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sites
  • Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website will:

  • Essential: Remember your cookie permission setting
  • Essential: Allow session cookies
  • Essential: Gather information you input into a contact forms, newsletter and other forms across all pages
  • Essential: Keep track of what you input in a shopping cart
  • Essential: Authenticate that you are logged into your user account
  • Essential: Remember language version you selected
  • Functionality: Remember social media settingsl Functionality: Remember selected region and country
  • Analytics: Keep track of your visited pages and interaction taken
  • Analytics: Keep track about your location and region based on your IP number
  • Analytics: Keep track of the time spent on each page
  • Analytics: Increase the data quality of the statistics functions
  • Advertising: Use information for tailored advertising with third parties
  • Advertising: Allow you to connect to social sitesl Advertising: Identify device you are using
  • Advertising: Gather personally identifiable information such as name and location

This website won't:

  • Remember your login details
Save & Close
Skip to content
Open toolbar

Accessibility Tools

  • Increase Text
  • Decrease Text
  • Grayscale
  • High Contrast
  • Negative Contrast
  • Light Background
  • Links Underline
  • Readable Font
  • Reset